It appears as though this stock is going back to the stone age, (back to the drawing board). It would be wise to re-invest once it's stabalised back at an all time low.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025